000			01611 a2200469 4500
005			20250514010610.0
264		0	_c20011207
008			200112s 0 0 eng d
022			_a0269-9370
024	7		_a10.1097/00002030-200109070-00018 _2doi
040			_aNLM _beng _cNLM
100	1		_aGougeon, M L
245	0	0	_aImmunological and virological effects of long term IL-2 therapy in HIV-1-infected patients. _h[electronic resource]
260			_bAIDS (London, England) _cSep 2001
300			_a1729-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aCD4 Lymphocyte Count
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aDNA, Viral _xblood
650	0	4	_aDidanosine _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV-1 _xphysiology
650	0	4	_aHumans
650	0	4	_aImmunologic Memory
650	0	4	_aInterleukin-2 _xtherapeutic use
650	0	4	_aReverse Transcriptase Inhibitors _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aZidovudine _xtherapeutic use
700	1		_aRouzioux, C
700	1		_aLiberman, I
700	1		_aBurgard, M
700	1		_aTaoufik, Y
700	1		_aViard, J P
700	1		_aBouchenafa, K
700	1		_aCapitant, C
700	1		_aDelfraissy, J F
700	1		_aLevy, Y
773	0		_tAIDS (London, England) _gvol. 15 _gno. 13 _gp. 1729-31
856	4	0	_uhttps://doi.org/10.1097/00002030-200109070-00018 _zAvailable from publisher's website
999			_c11469656 _d11469656